Design of a Miniature Pump for Chronic Mechanical Circulatory Support Using Computational Fluid Dynamics and Flow Visualization

Author(s):  
J. Ryan Stanfield ◽  
Richard K. Wampler ◽  
Jingchun Wu ◽  
James Stewart ◽  
Trevor A. Snyder ◽  
...  

Ventricular assist devices (VADs) have become an accepted method of treating end-stage heart failure over the last few decades. In recent years, the use of rotary blood pumps (RBPs) as continuous flow VADs has surged ahead, and virtually eliminated the use of pulsatile-flow or volume-displacement pumps for implantable, chronic mechanical circulatory support (MCS). As the use of RBPs has become commonplace for the treatment of end-stage heart failure, the need for an implantable right-side MCS device for adults [1] and implantable MCS for the pediatric population has increased. Development of an implantable device specific to these populations includes unique challenges of anatomic placement and fixation. Computational Fluid Dynamics (CFD) is the use of numerical methods and algorithms to solve and analyze problems involving fluid flow. CFD has become a standard tool when designing RBPs, as it can calculate pressure-flow characteristics for a given rotary impeller speed. Additionally, through calculation of shear forces, CFD can also predict hemocompatibility by means of constitutive equations derived from empirical data. Particle image velocimetry (PIV), also known as flow visualization, is an optical measurement technique used to obtain velocity in fluids, which can be employed experimentally to verify CFD-based predictions of flow field. PIV also permits more rapid investigation of the RBP operativing range and transient conditions than can be achieved with CFD due to computational requirements. We have developed a RBP platform for chronic use with CFD to optimize hemodynamic performance. The miniaturized device includes unique inlet geometry with a rotating impeller and a vaned-diffuser in a 7mm axial hydraulic diameter. The design scheme separates the bearing and motor region from the primary flow path to further improve hemocompatibility and reduce the pump size without compromising the hydraulic capacity. Here we report CFD and PIV results of our device geometry optimized for right-sided MCS.

2010 ◽  
Vol 6 (4) ◽  
pp. 22
Author(s):  
Patrycja Ganslmeier ◽  
Christof Schmid ◽  
◽  

Mechanical circulatory support for end-stage heart failure has become routine and is now increasingly used as definitive treatment. Several small devices qualify for this purpose, but only a few have gained US Food and Drug Administration (FDA) approval as yet. Several studies, including the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study, the Investigation of Non-transplant-Eligible Patients Who Are Inotrope Dependent (INTrEPID) and the HeartMate (HM) II trial have confirmed a significantly improved quality of life and functional capacity after device placement. However, cerebrovascular events, infection and device malfunction still pose a considerable risk to patients and hinder widespread use.


Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Sasan Partovi ◽  
Christoph Karmonik ◽  
Fabian Rengier ◽  
Matthias Mueller-Eschner ◽  
Hagen Meredig ◽  
...  

Introduction: Partial mechanical circulatory support (pMCS) is used for the therapy of heart failure. The CircuLite® Pump has been introduced clinically with its inflow cannula connected to the left atrium and the outflow cannula to the right subclavian artery. Aim of our study was to visualize and quantify flow patterns using computational fluid dynamics (CFD) in CT angiography (CTA). Methods: Two heart failure patients with pMCS were imaged with ECG-gated CTA and echocardiography. CFD was performed in 3D derived from CTA using flow boundary conditions measured with ultrasound. Flow was visualized using velocity vectors of blood flow. Average velocity was calculated at 10 time points during cardiac cycle in the aorta and the innominate. Wall shear stress (WSS) was visualized on the wall of the digital model. Results: Flow reversal was observed in mid-systole for both cases distal from the origin of the innominate artery in both cases due to asynchrony of the constant flow of the device with the pulsatile flow of the heart (fig.). Maximum velocity of this back flow was 0.39 m/s in case 1 and 0.2 m/s in case 2. Therefore, further distal in the innominate artery, a region of slow and stagnant flow with low WSS at the artery wall was observed which changed during cardiac cycle. Conclusions: CFD analysis revealed an asynchronous behavior in the inducted flow patterns during systole. Further design should allow for synchronization with the native heart function. Figure: On top flow during systole for both cases (case 1 on left), below flow during diastole. WSS is shown in pseudo-color representation with red indicating high values. Flow is visualized by arrows. During systole, a region of low WSS (blue) exists in the innominate artery which is absent during systole indicating flow reversal at this location. Bottom panel: Velocity in inferior-superior direction during cardiac cycle for both cases. Red lines demonstrates change of direction of flow in the innominate during systole.


2019 ◽  
Author(s):  
Dane A Coyne ◽  
Mitali P Shah ◽  
Kris M Mogensen ◽  
John C Klick

Heart failure is a devastating progressive disease process that is rising in incidence throughout the world. For patients with end-stage heart failure, orthotopic heart transplantation had been the only therapeutic option. Unfortunately, the number of patients requiring such therapy far exceeds the number of available organs. Recent advancements in technology have made implantable cardiac assist devices a reality. Outcomes with these devices are superior to maximal medical therapy and may serve either as a bridge to the availability of a donor organ or as “destination” therapy for the patient with end-stage heart failure. In addition, new technology can also provide temporary mechanical support for patients with acute decompensated cardiogenic shock, allowing preservation of end-organ function until more definitive long-term mechanical support can be coordinated. Patients with end-stage heart failure experience unique nutritional challenges. Mechanical circulatory support adds yet another unique dimension to the nutritional support challenges of this patient population. This review contains 2 figures, 5 tables, and 29 references. Key words: cardiogenic shock, enteral nutrition, extracorporeal membrane oxygenation, heart failure, mechanical circulatory support, nutritional support, parenteral nutrition, ventricular assist device


2014 ◽  
Vol 29 (5) ◽  
pp. 717-722 ◽  
Author(s):  
Antonio Loforte ◽  
Francesco Musumeci ◽  
Andrea Montalto ◽  
Emanuele Pilato ◽  
Paola Lilla Della Monica ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document